Kiniksa Pharmaceuticals International Plc. (NASDAQ:KNSA) traded at $25.12 at last check on Tuesday, July 23, made an upward move of 17.46% on its previous day’s price.
Looking at the stock we see that its previous close was $21.39. The company has a trailing 12-month PE ratio of 231.99. In terms of its 52-week price range, KNSA has a high of $22.65 and a low of $14.12. The company’s stock has gained about 35.01% over that past 30 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Kiniksa Pharmaceuticals International Plc. has a market cap of $1.78 billion.
Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Kiniksa Pharmaceuticals International Plc. (KNSA) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 25.14% off its SMA20 and 28.55% from its 50-day simple moving average. The RSI (14) is pointing at 78.10 while the volatility over the past week is 3.58% and jumps to 3.79% over the past one month. The beta value is 0.38, while the average true range (ATR) is currently pointing at 1.01. The average price target for the stock over the next 12 months is $34, with the estimates having a low of $34 and a high of $34. These price ends are -35.35% and -35.35% off the today’s price level respectively, although investors could be excited at the prospect of a -35.35% if the KNSA share price touches on the median price of $34.
Coming back to Kiniksa Pharmaceuticals International Plc. (NASDAQ:KNSA), we note that the average 3-month trading volume was 395.58K, while that of the preceding 10-day period stands at 0.42 million. Current shares outstanding are 70.94 million.
The insiders hold 45.58% of the company’s shares while institutions hold 51.62%. The data shows that short shares as of 2024-06-28, stood at 4.56 million at a short ratio of 10.52. This represents a 14.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.6414.64 short interest in shares outstanding on 2024-06-28. Shares short rose in June from the previous month at 4.12 million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock 43.24% up in year-to-date price movement.
